Mechanical aortic valve prostheses offer a survival benefit in 50-65 year olds: AUTHEARTVISIT study.
Denise TraxlerPavla KrotkaMaria LaggnerMichael MildnerAlexandra GrafBerthold ReichardtRalph WendtJohann AuerBernhard MoserJulia MascherbauerHendrik Jan AnkersmitPublished in: European journal of clinical investigation (2021)
Patients aged 50-65 years who underwent M-AVR had better long-term survival, and a lower risk of reoperation and myocardial infarction. Even though anticoagulation is crucial in patients with M-AVR, we did not observe significantly increased stroke rates in patients with M-AVR. This evident survival benefit in recipients of mechanical aortic valve prostheses aged <65 years critically questions current guideline recommendations.
Keyphrases
- aortic valve
- transcatheter aortic valve replacement
- transcatheter aortic valve implantation
- aortic stenosis
- aortic valve replacement
- end stage renal disease
- ejection fraction
- atrial fibrillation
- newly diagnosed
- chronic kidney disease
- heart failure
- prognostic factors
- venous thromboembolism
- peritoneal dialysis
- free survival
- clinical practice
- coronary artery disease
- brain injury